Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity
23 Fevereiro 2024 - 10:50AM
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the
“Company”), a medical device company focused on advancing
innovative technologies to revolutionize how diseases involving the
nervous system are diagnosed and treated, today announced that it
will present at the Virtual Investor Lunch Break: The Autonomix
Opportunity event on Thursday, February 29, 2024 at 12:00 PM ET.
As part of the event, Lori Bisson, Chief
Executive Officer of Autonomix, will provide a corporate overview,
business outlook, and discuss the Autonomix opportunity.
A live video webcast of the event will be
available on the Events page under the Investors section of the
Company’s website (autonomix.com). A webcast replay will be
available two hours following the live event and will be accessible
for 90 days.
About Autonomix Medical,
Inc.
Autonomix is a medical device company focused on
advancing innovative technologies to revolutionize how diseases
involving the nervous system are diagnosed and treated. The
Company’s first-in-class technology platform includes a
catheter-based microchip sensing array that has the ability to
detect and differentiate neural signals with approximately 3,000
times greater sensitivity than currently available technologies. We
believe this will enable, for the first time ever, transvascular
diagnosis and treatment of diseases involving the peripheral
nervous system virtually anywhere in the body.
We are initially developing our technology for
pancreatic cancer pain, a condition that can cause debilitating
pain and needs an effective solution. However, our technology
constitutes a platform with the potential to address dozens of
indications, including in cardiology, renal denervation and chronic
pain management across a wide disease spectrum.
For more information, visit autonomix.com and
connect with the Company on X, LinkedIn, Instagram and
Facebook.
Investor and Media Contact
JTC Team, LLCJenene Thomas 833-475-8247autonomix@jtcir.com
Autonomix Medical (NASDAQ:AMIX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Autonomix Medical (NASDAQ:AMIX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024